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INTRODUCTION
Acute necrotizing encephalopathy (ANE) is a unique acute
encephalopathy that predominantly affects infants and young
children (1). It is characterized by the features of acute ence-
phalopthy such as seizures and rapid alteration of conscious-
ness after a nonspecific viral illness. Since Mizuguchi et al.
proposed this condition as a new entity in 1995 (2), it has
occasionally been reported in both Asian and Western coun-
tries. An increased level of serum aminotransferase activiy
and cerebrospinal fluid protein, are the most common abnor-
malities (1-4). Diagnosis is made mainly by the characteris-
tic findings of computed tomography or magnetic resonance
imaging (MRI), which typically show symmetric lesions in
the thalami, with variable involvement of the white matter,
basal ganglia, brainstem, and cerebellum (1, 4, 5). Regard-
less of the treatment, the prognosis of ANE varies widely from
complete recovery to death (1-6). With the widespread use
of MRI, this unique condition is becoming more familiar.
However, the etiology, pathogenesis, guidelines of treatments,
or prognostic factors still remain unclear. In this report, we
described 6 children with ANE to elucidate the genetic pro-
pensity, the clinical/neuroradiological characteristics, the res-
ponse to medical treatment and prognostic factors. 
MATERIALS AND METHODS
A total of 6 children with ANE (aged 1 yr to 7 yr at onset,
3 males and 3 females) was evaluated. The patients were ad-
mitted to Kyungpook National University Hospital, Daegu,
Korea, from 1999 through 2007. Diagnosis was made main-
ly by clinical and radiological characteristics. Serological tests
or polymerase chain reaction for certain viruses such as Her-
pes simplex virus, cytomegalovirus, Epstein-Barr virus, influen-
za virus, and mycoplasma were done in 5 out of them. Brain
MRIs were taken in all patients at the time of initial presen-
tation. In a search of other clinically plausible causes, mito-
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Clinical Spectrum and Prognostic Factors of Acute Necrotizing
Encephalopathy in Children
This study was conducted to investigate the etiology, the clinical characteristics and
prognosis of acute necrotizing encephalopathy (ANE) in Korean children. Six chil-
dren (1 yr to 7 yr) patients with ANE were enrolled. They were diagnosed by clini-
cal and radiological characteristics and their clinical data were retrospectively ana-
lyzed. In a search of clinically plausible causes, brain MRI in all patients, mitochon-
drial DNA studies for mitochondrial encephalomyopathy, lactic acidosis, and stroke-
like episodes (MELAS) and myoclonus epilepsy and ragged red fibers (MERRF) in
four patients, and genomic typing on HLA DRB/HLA DQB genes in three patients
were performed. All had precedent illnesses and the main initial symptoms includ-
ed mental change (83%), seizures (50%), and focal deficits (50%). MRI revealed
increased T2 signal density in the bilateral thalami and/or the brainstem in all pati-
ents. Mitochodrial DNA studies for MELAS and MERRF were negative in those chil-
dren and HLA-DRB1*1401, HLA-DRB3*0202, and HLA-DQB1*0502 seemed to
be significant. A high dose steroid was given to all patients, which seemed to be
partly effective except for 2 patients. In conclusion, ANE is relatively rare, but can result
in serious neurological complication in children. Early detection and appropriate treat-
ment may lead to a better neurological outcome.
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chodrial DNA studies for mitochondrial encephalomyopa-
thy and lacticacidosis and strokelike episode (MELAS) and
myoclonus epilepsy and ragged red fibers (MERRF), partic-
ularly point mutation at nt 3243, nt 3271, nt 3252, nt 8344,
nt 8356, etc. in the tRNA were screened in four patients. In
addition, genomic typing was performed on HLA DRB/HLA
DQB genes using polymerase chain reaction (PCR)-SSOP/
SSP techniques with Gel immunoelectrophoresis in three pati-
ents. This clinical research was approved by Internal Review
Board (74005-1540).
RESULTS
A total of six children was enrolled in the study. Past medi-
cal histories were uneventful in all patients and they had nor-
mal developmental milestones. The family histories were also
unremarkable. No patients were exposed to any drugs or chemi-
cal substances known to cause toxic encephalopathies.
Clinical features of the subjects
Clinical characteristics of the subjects are summarized in
Table 1. All had precedent illnesses and five out of them (83%)
had fever. The initial neurological symptoms include men-
tal change in five patients (83%), seizures (50%) and focal
neurological signs (50%).
Laboratory findings
Table 2 shows laboratory findings of the subjects. Increas-
ed level of serum aminotransferase and lactic dehydrogenase
activities may indicate hepatic dysfunction, but their levels
varied highly from case to case. Four patients (67%) showed
elevation of serum aminotransferase, which increased sharply
to 7,000 U/L in 2 out of them. Severe cases revealed laboratory
findings compatible with disseminated intravascular coagu-
lation but the clinical symptoms were almost absent. In addi-
tion, serum ammonia levels were normal. Serological tests or
polymerase chain reaction for certain viruses such as Herpes
simplex virus, cytomegalovirus, Epstein-Barr virus, influenza
virus, and mycoplasma were unremarkable. Mitochodrial DNA
studies for MELAS and MERRF were done in 4 patients, and
none of them showed any mutations. Genomic typing of HLA
DRB/HLA DQB genes in three patients (patient 3, 4, and 5)
using PCR-SSOP/SSP techniques with gel immunoelectro-
phoresis showed HLA-DRB1*1401, HLA-DRB3*0202, and
HLA-DQB1*0502 which were possibly significant (Table 3).
Cerebrospinal fluid study revealed normal protein levels in
all patients and mild pleocytosis in one patient (patient 4).
Herpes IgM antibody, oligoclonal band and myelin basic pro-
tein were unremarkable in all subjects.
Radiological findings
As shown in Fig. 1, brain MRI revealed increased signal
*Status epilepticus.
ANE, acute necrotizing encephalopathy; NSFI, non specific febrile illness; URI, upper respiratory tract infection; BG, Basal ganglia; T, Thalamus; TT,
Thalamotegmantum; P, Pons; C, Cerebellum.
Patient No. Age (month) Sex Precedent illnesses Initial presentation Sites of involvement 
1 93 F NSFI Diplopia BG, T, P, C
2 19 M URI & diarrhea Stupor/Rigidity TT
3 40 F NSFI Stupor/Seizure* BG, T
4 68 M NSFI Drowsiness/Gait disturbance TT
5 73 F NSFI Stupor/Seizure T, P, C
6 88 M URI Stupor/Seizure TT
Table 1. Clinical features of the subjects with ANE
ANE, acute necrotizing encephalopathy; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ND, not done; MBP, myelin basic protein;
mtDNA, mitochondrial DNA.
Patient
No.
AST/ALT
(U/L)
Ammonia
(mg/dL)
Glucose
(mg/dL)
Cerebrospinal fluid
Glucose
(mg/dL)
Protein
(mg/dL)
Cell
count (mL)
MBP
Oligoclonal
band
Herpes
IgM
mtDNA
mutations
1 26/9 145 14 0 29 83 ----
2 114/42 85 32 0 39 76 ----
3 7,000/4354 96 48 0 30 65 ND ND ND ND
4 34/15 85 24 66 40 61 - ND ND ND
5 128/44 135 24 0 43 90 - ND ND ND
6 7,725/2,910 108 56 0 46 61 ND ND ND ND
Table 2. Laboratory findings of the subjects with ANEAcute Necrotizing Encephalopathy in Children 451
density on T2-weighted imaging in the bilateral thalami and
brain stem in almost all patients. Two out of them had lesions
in cerebellum (Table 1). The findings were consistent with a
unique pattern of ANE. Follow-up MRI was done in 2 weeks
to 7 months. In one patient, brain findings had completely
resolved, However, in 4 patients of 5 followed-up, a certain
degree of sequelae were found (Table 4). 
Treatment and outcome
With respect to the treatment, steroids have been used in
two regimens: intravenous dexamethasone (patient 2, 3, 6) or
methylprednisolone pulse therapy (patient 1, 4, 5). In the dex-
amethasone group, 1 mg/kg/day of dexamethasone was ad-
ministered in 4 divided doses for at least 5 days. In the methyl-
prednisolone group, 30 mg/kg/day of methylprednisolone
was administrered for 5 days. As shown in Table 4, a patient
(patient 1) showed excellent outcomes without any neurolog-
ical sequelae at 6 months after the illness. The other three
patients (patient 2, 3, 4) showed a relatively good to fair out-
come. Even though they had initial weakness, spasticity on
extremities or memory disturbance, their symptoms improv-
ed remarkably. Two patients developed epilepsy later on and
required prophylactic antiepileptic drugs. Even so, they rema-
ined seizure free for more than years, and eventually were taken
off antiepileptic drugs without any sequelae. A patient (pati-
ent 6) died of cardiorespiratory compromise.
DISCUSSION
ANE was proposed as a novel disease entity by Mizuguchi
et al. in 1995 (2). Patients with ANE manifest fulminating
neurologic deterioration with preceding non-specific febrile
illness and frequently undergo intractable convulsions. Seri-
ous neurological signs such as decorticate, decerebrate postur-
ing or long tract signs may appear. Its mortality is considered
to reach as high as 30% (1, 2). Mizuguchi et al. proposed the
following diagnostic criteria for acute necrotizing encephalopa-
thy: 1) acute encephalopathy following a viral febrile disease
and rapid deterioration in the level of consciousness, convul-
sion; 2) increased cerebrospinal fluid (CSF) protein without
CSF pleocytosis; 3) CT or MRI findings for symmetric, multi-
focal brain lesions involving bilateral thalami, cerebral peri-
ventricular white matter, internal capsule, putamen, upper
brain stem tegmentum and cerebellar medulla without involve-
ment of other CNS regions; 4) elevation of serum aminotras-
ferase of variable degrees without hyperammonemia; 5) exclu-
ANE, acute necrotizing encephalopathy.
DRB1 Patient No. DRB3 DQB1
1 0701 1401 0202 0303 0502
2 1101 1401 0202 0301 0502
3 0101 1302 0301 0501 0609
Table 3. HLA-DRB and DQB alleles of 3 patients with ANE
*Definition of outcome.
Excellant, complete resolution; Good, almost complete resolution or mini-
mal degree of neurological sequelae (mobile, almost no cognitive/social/
emotional impairment); Fair, moderate degree of neurological seque-
lae (mobile with difficulty, mild to moderate cognitive/social/emotional
impairment); Poor, severe degree of neurological sequelae (immobile,
severe cognitive/social/emotional impairment).
Patient
No.
Follow-up 
MRI
Treatment
Neurological 
outcome
at 6 months
1 Methylprednisolone pulse Complete resolution Excellent
2 Dexamethasone 50-75% resolution Fair
3 Dexamethasone 50-75% resolution Fair
4 Methylprednisolone pulse >75% resolution Good
5 Methylprednisolone pulse <50% resolution Poor
6 Dexamethasone Not done Poor
Table 4. Treatment and its outcome in the subjects with ANE
Fig. 1. Radiological findings in a patient with ANE. (A) MRI shows symmetric, multifocal brain lesions involving bilateral thalami and upper
brain stem tegmentum without involvement of other CNS regions. (B) Follow-up MRI shows complete resolution of previous lesions. 
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sion of other resembling diseases such as overwhelming bac-
terial and viral infections, fulminant hepatitis, Reye syndrome,
Leigh encephalopathy and related mitochondrial cytopathies,
acute disseminated encephalomyelitis or other types of ence-
phalitis, vasculitis, cerebral infarction, and so on (1). Despite
the fact that Mizuguchi et al. proposed the diagnostic criteria
of ANE, atypical or milder cases have been reported. Yoshi-
kawa et al. suggested clinical diversity in ANE. They expe-
rienced 2 atypical cases that had selective reversible thalam-
ic involvement and milder clinical manifestations, and that
ended up in complete recovery without any sequelae (4). Pati-
ents with normal cerebrospinal fluid protein and low levels
of trasnsaminase, asymmetric thalamic involvement and no
lesion in the brain stem tend to recover well (6). Considering
the fact that ANE is a rare neurological condition, we expe-
rienced a variety of different cases. They met the diagnostic
criteria proposed by Mizuguchi et al. (2).
ANE is known to be one of the neurological complications
of viral infections, such as influenza A and B, human herpes-
virus 6, varicella zoster or mycoplasmal infection (7-14). In
addition, it is reportedly associated with the measles virus in
an animal study (15). Serological tests or polymerase chain
reaction for certain viruses, and mycoplasma were unremark-
able in our study. As shown in Table 2, the subjects showed
various results in laboratory findings. Interestingly CSF pro-
tein was within the normal range in all cases, but all had typi-
cal thalamic involvement on the images. In an attempt to ex-
clude other resembling encephalopathies, Herpes IgM, oligo-
clonal band and myelin basic proteins in CSF were examined
and shown unremarkable findings in most cases. Mutations
of the mitochondrial DNA were screened to rule out mito-
chondrial encephalopathies in four out of subjects, which all
came back negative (16, 17). Considering the fact of their sim-
ilarity to mitochondrial disorders on brain MRI, we believe
that mitochondrial dysfunction is partly related in this con-
dition, whether primary or not.
As is already known, ANE is a relatively uncommon form
of acute encephalopathy especially in East Asia, although Euro-
pean and American cases have been reported. It is thought
to have some racial or geographic predilection (1, 6). In this
study the HLA typing of 3 patients with ANE were evalu-
ated to see genetic propensity. Genomic typing was perform-
ed on their HLA DRB/HLA DQB genes and HLA-DRB1*
1401, HLA-DRB3*0202, and HLA-DQB1*0502 were found
to be significant as compared with known data of HLA alleles
in Korean (Table 3) (18). This is the first study using genom-
ic typing of HLA DRB/HLA DQB genes that has never been
done so far and the results may provide the immunogenetic
background of ANE. However, further studies are needed
to elucidate the condition. 
A postmortem examination of the central nervous system
could not be conducted, but bilateral thalamic necrosis is the
histological hallmark of acute necrotizing encephalopathy.
Selective vulnerability of the thalami seems to be a determin-
ing factor in acute necrotizing encephalopathy, because the
affected areas are generally supplied by the terminal branch-
es of the intracerebral arteries (3). It showed fresh necrosis,
brain edema in the margin of the lesion, and petechiae and
congestion (5, 19). A local breakdown of the blood-brain bar-
rier and an immunogenetic mechanism were suggested as
the pathogenesis of acute necrotizing encephalopathy (3). It
has also been suggested that the ischemic and necrotic pro-
cess from vasculitis or hypoxic injuries are related to the rapid
deterioration in ANE (10, 20). Some cytokine-mediated pro-
cesses may play a role in ANE (1, 2, 4, 10, 21). Patients with
ANE often have signs of systemic inflammatory response such
as shock, multiple organ failure, and disseminated intravas-
cular coagulation. This indicates that macrophage activation
and hypercytokinemia may be involved in the pathogenesis
of ANE (22). 
As illustrated in Fig. 1, almost all subjects showed radio-
logically pathognomonic findings of ANE. Based on previ-
ously limited experience, the MRI of brain seems to be a very
important diagnostic tool in ANE. With respect to the treat-
ment for ANE, anti-inflammatory treatment may be effective
(22-24). As shown in Table 4, the result of this study indicates
early methylprednisolone pulse therapy seems to be partly
effective for the children with ANE. However, well designed,
comparative, multi-center studies are still required to evalu-
ate the effectiveness of the regimen. 
Regarding the outcome in patients, younger than 2 yr of
age, those with high serum aminotransferase level, high pro-
tein levels of cerebrospinal fluid, and those with brain stem
lesions are thought to be poor prognostic factors (3-7, 10). In
other reports, reversible or asymmetric brain involvement,
focal neurologic signs showed a relatively fair prognosis (4,
8, 25). In this study, we experienced 6 patients with differ-
ent manifestation of ANE. They ended up having relatively
fair to good results except for two bad outcomes (patient 5,
6). As mentioned earlier, we believe that high dose steroid is
fairly effective and can be a prognostic determinant when used
in earlier stages of treatment. Findings on follow-up MRI
seem to allow us to predict the outcome as shown in Table 4.
In addition, it is confirmed that normal serum aminotrans-
ferase level, normal protein level of cerebrospinal fluid, and
few neurological signs may be good prognostic factors for
ANE. 
In conclusion, ANE is an uncommon neurological compli-
cation of acute infection in children and is to be further elu-
cidated in many aspects. However, early detection and appro-
priate treatment may lead to better neurological outcomes.
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